EBioMedicine (Dec 2017)

Proposed Terminology and Classification of Pre-Malignant Neoplastic Conditions: A Consensus Proposal

  • Peter Valent,
  • Cem Akin,
  • Michel Arock,
  • Christoph Bock,
  • Tracy I. George,
  • Stephen J. Galli,
  • Jason Gotlib,
  • Torsten Haferlach,
  • Gregor Hoermann,
  • Olivier Hermine,
  • Ulrich Jäger,
  • Lukas Kenner,
  • Hans Kreipe,
  • Ravindra Majeti,
  • Dean D. Metcalfe,
  • Alberto Orfao,
  • Andreas Reiter,
  • Wolfgang R. Sperr,
  • Philipp B. Staber,
  • Karl Sotlar,
  • Charles Schiffer,
  • Giulio Superti-Furga,
  • Hans-Peter Horny

DOI
https://doi.org/10.1016/j.ebiom.2017.11.024
Journal volume & issue
Vol. 26, no. C
pp. 17 – 24

Abstract

Read online

Cancer evolution is a step-wise non-linear process that may start early in life or later in adulthood, and includes pre-malignant (indolent) and malignant phases. Early somatic changes may not be detectable or are found by chance in apparently healthy individuals. The same lesions may be detected in pre-malignant clonal conditions. In some patients, these lesions may never become relevant clinically whereas in others, they act together with additional pro-oncogenic hits and thereby contribute to the formation of an overt malignancy. Although some pre-malignant stages of a malignancy have been characterized, no global system to define and to classify these conditions is available. To discuss open issues related to pre-malignant phases of neoplastic disorders, a working conference was organized in Vienna in August 2015. The outcomes of this conference are summarized herein and include a basic proposal for a nomenclature and classification of pre-malignant conditions. This proposal should assist in the communication among patients, physicians and scientists, which is critical as genome-sequencing will soon be offered widely for early cancer-detection.

Keywords